MiniMed Group Common Stock Receivables

MiniMed Group Common Stock (MMED) currently reports a receivables of $660M as of April 2026. That compares with $570M in the prior-year period — up 14.9% year over year. Use the charts on this page to explore MiniMed Group Common Stock's receivables history and peer comparisons.

MiniMed Group Common Stock's receivables increased from $570M to $660M — a 14.9% year-over-year increase (period ending April 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

MiniMed Group Common Stock reported $660M in receivables as of April 2026. That compares with $570M in the prior-year period — up 14.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $660M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for MiniMed Group Common Stock, and consider following MMED for alerts when major investors trade the stock.